Yiannis is a serial entrepreneur and globally respected leader in the life sciences and regenerative medicine fields. He oversees all of SpringTide’s life sciences and med-tech investing and serves as an advisor to the investment committee.
Yiannis has created and managed several companies and had four exits totaling in excess of $500 million, including an IPO.
Yiannis earned his bachelor’s degree from Columbia University, his MS and PhD degrees from Stanford University, and his MBA from Harvard Business School.